Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In animal models, E1-deleted human adenoviral recombinants of the serotype 5 (AdHu5) have shown high efficacy as vaccine carriers for different Ags including those of HIV-1. Humans are infected by common serotypes of human adenovirus such as AdHu5 early in life and a significant percentage has high levels of neutralizing Abs to these serotypes, which will very likely impair the efficacy of recombinant vaccines based on the homologous virus. To circumvent this problem, a novel replication-defective adenoviral vaccine carrier based on an E1-deleted recombinant of the chimpanzee adenovirus 68 (AdC68) was developed. An AdC68 construct expressing a codon-optimized, truncated form of gag of HIV-1 induces CD8(+) T cells to gag in mice which at the height of the immune response encompass nearly 20% of the entire splenic CD8(+) T cell population. The vaccine-induced immune response provides protection to challenge with a vaccinia gag recombinant virus. Induction of transgene-specific CD8(+) T cells and protection against viral challenge elicited by the AdC68 vaccines is not strongly inhibited in animals preimmune to AdHu5 virus. However, the response elicited by the AdHu5 vaccine is greatly attenuated in AdHu5 preimmune animals.

Original publication

DOI

10.4049/jimmunol.170.3.1416

Type

Journal article

Journal

J Immunol

Publication Date

01/02/2003

Volume

170

Pages

1416 - 1422

Keywords

Adenovirus E1 Proteins, Adenoviruses, Human, Adenoviruses, Simian, Animals, CD8-Positive T-Lymphocytes, Cell Line, Epitopes, T-Lymphocyte, Female, Gene Deletion, Gene Expression Regulation, Viral, Gene Products, gag, HIV-1, Humans, Kinetics, Lymphocyte Activation, Mice, Mice, Inbred BALB C, Pan troglodytes, Transgenes, Tumor Cells, Cultured, Vaccines, Synthetic, Viral Vaccines, Virus Replication